Literature DB >> 19110986

Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives.

Ana Beleza-Meireles1, Ammar Al-Chalabi.   

Abstract

The genetic causes of amyotrophic lateral sclerosis (ALS) are slowly being dissected out with the help of recent advances in genetic technology. Linkage studies and association studies examining candidate genes, candidate pathways, and genome-wide association have been used, based on direct sequencing and correlations between genetic variations. Copy number and microsatellite variants have also been examined, although the ideal methods for analysis are still being developed. In this review we examine the evidence for a genetic basis to ALS, discuss the challenges and difficulties faced and summarize the support for the reported genetic causes of ALS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19110986     DOI: 10.1080/17482960802585469

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  31 in total

1.  Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials.

Authors:  Albert C Ludolph; Sarah Jesse
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

Review 2.  ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration.

Authors:  John M Ravits; Albert R La Spada
Journal:  Neurology       Date:  2009-09-08       Impact factor: 9.910

Review 3.  Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects.

Authors:  Sumeet Kumar; Navneesh Yadav; Sanjay Pandey; B K Thelma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

4.  7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis.

Authors:  Orhan Tansel Korkmaz; Nurgul Aytan; Isabel Carreras; Ji-Kyung Choi; Neil W Kowall; Bruce G Jenkins; Alpaslan Dedeoglu
Journal:  Neurosci Lett       Date:  2014-03-15       Impact factor: 3.046

Review 5.  Clinical diagnosis and management of amyotrophic lateral sclerosis.

Authors:  Orla Hardiman; Leonard H van den Berg; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

6.  δ-Opioid receptors up-regulate excitatory amino acid transporters in mouse astrocytes.

Authors:  Jianfeng Liang; Dongman Chao; Harleen K Sandhu; Yanbing Yu; Li Zhang; Gianfranco Balboni; Dong H Kim; Ying Xia
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

7.  Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS.

Authors:  Patricia S Estes; Ashley Boehringer; Rebecca Zwick; Jonathan E Tang; Brianna Grigsby; Daniela C Zarnescu
Journal:  Hum Mol Genet       Date:  2011-03-26       Impact factor: 6.150

Review 8.  Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.

Authors:  Stefanie M A Willekens; Donatienne Van Weehaeghe; Philip Van Damme; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-08       Impact factor: 9.236

9.  The role of copy number variation in susceptibility to amyotrophic lateral sclerosis: genome-wide association study and comparison with published loci.

Authors:  Louise V Wain; Inti Pedroso; John E Landers; Gerome Breen; Christopher E Shaw; P Nigel Leigh; Robert H Brown; Martin D Tobin; Ammar Al-Chalabi
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

10.  Sporadic ALS has compartment-specific aberrant exon splicing and altered cell-matrix adhesion biology.

Authors:  Stuart J Rabin; Jae Mun Hugo Kim; Michael Baughn; Ryan T Libby; Young Joo Kim; Yuxin Fan; Randell T Libby; Albert La Spada; Brad Stone; John Ravits
Journal:  Hum Mol Genet       Date:  2009-10-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.